# Bioavailability of Apixaban Crushed Tablet

> **NCT02101112** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 69 (actual)

## Conditions studied

- Thrombosis

## Interventions

- **DRUG:** Apixaban

## Key facts

- **NCT ID:** NCT02101112
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2016-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02101112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02101112, "Bioavailability of Apixaban Crushed Tablet". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02101112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*